Related references
Note: Only part of the references are listed.Cured Today, Ill Tomorrow: A Method for Including Future Unrelated Medical Costs in Economic Evaluation in England and Wales
Meg Perry-Duxbury et al.
VALUE IN HEALTH (2020)
Practical Guidance for Including Future Costs in Economic Evaluations in The Netherlands: Introducing and Applying PAID 3.0
Klas Kellerborg et al.
VALUE IN HEALTH (2020)
A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending
Pieter van Baal et al.
HEALTH ECONOMICS (2019)
Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
Linda M. de Vries et al.
PHARMACOECONOMICS (2019)
HEAD TO HEAD Should cost effectiveness analyses for NICE always consider future unrelated medical costs?
Pieter van Baal et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
HEAD TO HEAD Should cost effectiveness analyses for NICE always consider future unrelated medical costs?
Pieter van Baal et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal
Alec Morton et al.
HEALTH ECONOMICS (2016)
On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?
Laura Vallejo-Torres et al.
VALUE IN HEALTH (2016)
Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost-Effectiveness Analysis
Pieter Van Baala et al.
HEALTH ECONOMICS (2016)
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
Karl Claxton et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
Systematic overview of cost-effectiveness thresholds in ten countries across four continents
Ruth Schwarzer et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2015)
Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room
Simon Eckermann et al.
PHARMACOECONOMICS (2014)
NICE's Cost-Effectiveness Range: Should it be Lowered?
J. P. Raftery
PHARMACOECONOMICS (2014)
Comparing costs and outcomes across programmes of health care
Stephen Martin et al.
HEALTH ECONOMICS (2012)
The Economics of the NHS Cancer Drugs Fund
Alan Maynard et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2011)
Searching for cost effectiveness thresholds in the NHS
John Appleby et al.
HEALTH POLICY (2009)
Unrelated Medical Costs in Life-Years Gained Should They be Included in Economic Evaluations of Healthcare Interventions?
David R. Rappange et al.
PHARMACOECONOMICS (2008)